The amniotic membrane market consists of amniotic membranes harvested from human placentas that are used extensively for wound healing and in various medical applications such as ophthalmology, surgical, orthopedic, and dental procedures. Amniotic membranes aid in healing by reducing inflammation and scarring. They act as a biological barrier and promote re-epithelization. The rising prevalence of chronic wounds worldwide coupled with the advantages of amniotic membranes like faster healing, minimal scarring, and low risk of rejection by the recipient's body are driving the demand for amniotic membrane products. The Global amniotic membrane market is estimated to be valued at US$ 3.62 Bn in 2023 and is expected to exhibit a CAGR of 13% over the forecast period of 2024-2031.
Key Takeaways
Key players operating in the Amniotic Membrane market are Smith & Nephew, Applied Biologics, Organogenesis Holdings Inc., Osiris Therapeutics, Inc., Alliqua BioMedical, Inc., Amnio Technology, LLC, Next Biosciences, Integra LifeSciences, MiMedx, LifeCell International, Human Regenerative Technologies, LLC, Amniox Medical, Inc, Skye Biologics Inc., Wright Medical, TissueTech, Katena Products, Inc., NuVision Biotherapies, Surgenex, and Ventris Medical. The rising prevalence of chronic diseases and traumatic injuries worldwide are creating lucrative opportunities for players in the amniotic membrane market. Additionally, increasing R&D investments by manufacturers for development of advanced wound care products are further fueling market growth.
Major players are focusing on expanding their geographical presence through partnerships and acquisitions. For instance, in 2021, Organogenesis acquired Advanced BioTherapeutics to expand its portfolio of regenerative medicine products. Similarly, Smith & Nephew acquired Osiris Therapeutics to strengthen its advanced wound management products portfolio. With rising demand, players are also focusing on emerging markets like Asia Pacific and Latin America which are expected to exhibit high growth during the forecast period.
Market drivers:
The growing prevalence of chronic wounds such as diabetic foot ulcers, pressure ulcers, and venous leg ulcers is a major market driver. Amniotic membranes are highly effective in treatment of such hard-to-heal wounds. Additionally, rising incidence of burns cases and traumatic injuries globally are also fueling demand. Further, increasing preference for advanced wound care products and tissue-engineered skin substitutes over traditional wound dressing products is propelling market growth.
Market restraints:
High cost of amniotic membrane products and challenges in obtaining reimbursements are major restraints hampering wide adoption. Additionally, stringent regulatory approvals and ethical issues regarding the use of human tissues also restrict market growth. Requirement of specialized sterile facilities for processing and handling of amniotic tissues further increases production costs.
Segment Analysis
The dried amniotic membrane sub segment dominates the amniotic membrane market currently. Amniotic membrane is dried and processed to form a dehydrated powder or sheet. This makes it easier to store and transport for extended period of time. Its shelf life is also increased when dried as compared to fresh or cryopreserved form. Dried amniotic membrane has wide range of applications in wound care including healing chronic ulcers, burns, surgical wound repair etc. It promotes wound healing through its anti-fibrotic, anti-microbial and anti-scarring properties.
Global Analysis
North America region presently accounts for the largest market share in the global amniotic membrane market. This is attributed to factors such as rising prevalence of chronic wounds, increasing volume of burns injuries and surgeries in the region. Moreover, developed healthcare infrastructure, availability of advanced wound care products and favorable reimbursement policies support market growth in North America. Asia Pacific region is expected to grow at fastest pace during forecast period. Improving healthcare standards, growing medical tourism industry and rising awareness about amniotic membrane benefits for wound healing in Asia Pacific countries will boost market expansion.
